MYC and cervical cancer: In summary, GF2 increased the cytotoxicity and the sub-G1 phase along with the suppression of pro-PARP, pro-cas3, Wnt, β-catenin, c-Myc, HK2, LDHA, and PKM2 in cervical cancer cells.